BUY Divi's Laboratories Limited — Dhvani Patel
byDhvani PatelHorizon: NA (inferred Swing (≤2wk))16 Jun 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·23 Jun · today
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·14 May · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- SELL — Prakash Gaba14 Oct 2026 · ~2 weeks · target ₹8,750 · SL hit
- SELL — Mehul Kothari, Anand Rathi14 Oct 2026 · ~2 weeks · target ₹8,400 · Active
- BUY — Kavita Jain, Arihant Capital Markets6 Oct 2026 · Next day · target ₹9,750 · Expired
- BUY — Chandan Taparia, Motilal Oswal24 Sept 2026 · ~2 weeks · target ₹10,000 · SL hit
- BUY — Manas Jaiswal23 Sept 2026 · ~2 weeks · target ₹9,900 · SL hit
More from Dhvani Patel
- BUY The Phoenix Mills15 Oct 2026 · ~2 weeks · target ₹2,100 · Active
- BUY Manappuram Finance15 Oct 2026 · ~2 weeks · target ₹370 · SL hit
- BUY Cholamandalam Investment and Finance Company9 Oct 2026 · ~2 weeks · target ₹1,660 · SL hit
- SELL United Spirits8 Oct 2026 · ~2 weeks · target ₹1,280 · SL hit
- SELL PB Fintech8 Oct 2026 · ~2 weeks · target ₹950 · SL hit

